{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:10:25Z","timestamp":1759533025883,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.arbres.2023.04.002","type":"journal-article","created":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T16:43:36Z","timestamp":1682009016000},"page":"512-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cystic Fibrosis\u2013Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma"],"prefix":"10.1016","volume":"59","author":[{"given":"Miguel","family":"Jim\u00e9nez-G\u00f3mez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo Magdalena","family":"D\u00edaz Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla","family":"Diab C\u00e1ceres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10290","key":"10.1016\/j.arbres.2023.04.002_bib0025","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.arbres.2023.04.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1007\/s11882-020-00985-7","article-title":"Asthma in cystic fibrosis: definitions and implications of this overlap syndrome","volume":"21","author":"Marion","year":"2021","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.arbres.2023.04.002_bib0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2213-2600(12)70058-9","article-title":"How the airway smooth muscle in cystic fibrosis reacts in proinflammatory conditions: implications for airway hyper-responsiveness and asthma in cystic fibrosis","volume":"1","author":"McCuaig","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.arbres.2023.04.002_bib0040","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jcf.2016.01.003","article-title":"Reversible airway obstruction in cystic fibrosis: common, but not associated with characteristics of asthma","volume":"15","author":"Levine","year":"2016","journal-title":"J Cyst Fibros"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289623001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:42:42Z","timestamp":1759531362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289623001266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0300289623001266"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2023.04.002","relation":{},"ISSN":["0300-2896"],"issn-type":[{"type":"print","value":"0300-2896"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic Fibrosis\u2013Asthma Overlap Syndrome. Combination of Cystic Fibrosis Transmembrane Conductance Regulator Modulators and Type 2 Targeted Biologic Treatment for Asthma","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2023.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 SEPAR. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}